Age-dependent impairment of angiogenesis

Circulation

Volumn 99, Issue 1, 1999, Pages 111-120

  Rivard, Alain ^a   Fabre, Jean Etienne ^a   Silver, Marcy ^a   Chen, Dongfen ^a   Murohara, Toyoaki ^a   Kearney, Marianne ^a   Magner, Meredith ^a   Asahara, Takayuki ^a   Isner, Jeffrey M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Aging; Angiogenesis; Endothelium; Growth substances

Indexed keywords

AGING; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HINDLIMB; IMMUNOHISTOCHEMISTRY; LIMB ISCHEMIA; LIMB PERFUSION; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR DISEASE;

EID: 0033547805     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.1.111     Document Type: Article

References (41)

1. Kannel WB, Gordon T. Cardiovascular risk factors in the aged: the Framingham study. In: Haynes SG, Feinleib M, eds. Epidemiology of Aging. Bethesda, Md: National Institutes of Health; 1980:65-98.
2. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest. 1994;93:662-670.
3. Takeshita S, Rossow ST, Kearney M, Zheng LP, Bauters C, Bunting S, Ferrara N, Symes JF, Isner JM. Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol. 1995;147:1649-1660.
4. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg. 1992;16:181-191.
5. Yang HT, Deschenes MR, Ogilvie RW, Terjung RL. Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ Res. 1996;79:62-69.
6. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183-2189.
7. Pearlman JD, Hibberd MG, Chuang ML, Harada K, Lopez JJ, Gladston SR, Friedman M, Sellke FW, Simons M. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nat Med. 1995;1:1085-1089.
8. Giordano FJ, Ping P, McKirnan D, Nozaki S, DeMaria AN, Dillmann WH, Mathieu-Costello O, Hammond HK. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med. 1996;2:534-539.
9. Takeshita S, Tsurumi Y, Couffinhal T, Asahara T, Bauters C, Symes JF, Ferrara N, Isner JM. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest. 1996;75:487-502.
10. 165. Lancet. 1996;348: 370-374.
11. Weisbroth SH. Neoplastic diseases. In: Weisbroth SH, Flatt HE, Kraus AL, eds. The Histology of the Laboratory Rabbit. New York, NY: Academic Press; 1974:331.
12. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, Isner JM. Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation. 1997;95:1030-1037.
13. Zheng LP, Couffinhal T, Sheriff DD, Horowitz J, Isner JM. A mouse model of angiogenesis. Circulation. 1994;92(suppl I):I-750. Abstract.
14. Couffinhal T, Silver M, Kearney M, Sullivan A, Isner JM. Angiogenesis is impaired in ApoE knock out mice due to reduced expression of vascular endothelial growth factor. Circulation. 1996;94(suppl I):I-102. Abstract.
15. Couffinhal T, Kearney M, Witzenbichler B, Chen D, Murohara T, Losordo DW, Symes JF, Isner JM. Vascular endothelial growth factor/ vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries. Am J Pathol. 1997;150:1673-1685.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
17. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, while hypoxia upregulates VEGF expression only. Circulation. 1994;90:649-652.
18. Tsurumi Y, Murohara T, Krasinski K, Dongfen C, Witzenbichler B, Kearney M, Couffinhal T, Isner JM. Reciprocal relationship between VEGF and NO in the regulation of endothelial integrity. Nat Med. 1997;3:879-886.
19. D'Amore PA, Thompson RW. Mechanisms of angiogenesis. Annu Rev Physiol. 1987;49:453-464.
20. Tomanek RJ, Aydelotte MR, Torry RJ. Remodeling of coronary vessels during aging in purebred beagles. Circ Res. 1991;69:1068-1074.
21. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, Malinski T, Luscher TF. Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest. 1996;98:899-905.
22. Gerhard M, Roddy M-A, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension. 1996;27:849-853.
23. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Fasolo B, Sudano I, Salvetti A. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation. 1995;91:1981-1987.
24. Paterno R, Faraci FM, Heistad DD. Age-related changes in release of endothelium-derived relaxing factor from the carotid artery. Stroke. 1994; 25:2459-2462.
25. Phillips GD, Stone AM. PDGF-BB induced chemotaxis is impaired in aged capillary endothelial cells. Mech Ageing Dev. 1994;73:189-196.
26. Garfinkel S, Hu X, Prodovsky IA, McMahon GA, Kaqpnik EM, McDowell SD, Maciag T. FGF-1-dependent proliferative and migratory responses are impaired in senescent human umbilical vein endothelial cells and correlate with the inability to signal tyrosine phosphorylation of fibroblast growth factor receptor-1 substrates. J Cell Biol. 1996;1345: 783-791.
27. Koch A, Harlow L, Haines G, Amento E, Unemori E, Wong W, Pope R, Ferrara N. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994;152: 4149-4156.
28. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Theme H, Iwamoto MA, Parke JE, Nguyen MD, Aiello LM, Ferrara N, King GL. Vascular endothelial growth factor in ocular fluids of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
29. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
30. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE, Klagsbrun M. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 1995;55: 4140-4145.
31. Miller RA. The aging immune system: primer and prospectus. Science. 1996;273:70-74.
32. Linton P-J, Haynes L, Klinman NR, Swain SL. Antigen-independent changes in naive CD4T cells with aging. J Exp Med. 1996;184: 1891-1900.
33. Stohlawetz P, Kolussi T, Jahandideh-Kazempour S, Kudlacek S, Graninger W, Willvonseder R, Pietschmann P. The effect of age on the transendothelial migration of human T lymphocytes. Scand J Immunol. 1996;44:530-534.
34. Pryce G, Male D, Campbell I, Greenwood J. Factors controlling T-cell migration across rat cerebral endothelium in vitro. J Neuroimmunol. 1997;75:84-94.
35. Ichinose K, Nakamura T, Nishiura Y, Tsujino A, Goto H, Shirabe S, Furuya T, Nagataki S. Characterization of T cells transmigrating through human endothelial cells in patients with HTLV-1-associated myelopathy. Immunobiol. 1996;196:485-490.
36. Kreisle RA, Stebler BA, Ershler WB. Effect of host age on tumor-associated angiogenesis in mice. J Natl Cancer Inst. 1990;82:44-47.
37. Pili R, Guo Y, Chang J, Nakanishi H, Martin GR, Passaniti A. Altered angiogenesis underlying age-dependent changes in tumor growth. J Natl Cancer Inst. 1994;86:1303-1314.
38. + murine T lymphocytes, and its production declines with age. Cancer Immunol Immunother. 1988;26:31-34.
39. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation. 1995;92:11-14.
40. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation. 1998;97: 381-390.
41. Warren RS, Yuan H, Matli MR, Ferrara N, Donner DB. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J Biol Chem. 1996;271:29483-29488.